Issue 8/2023
Content (6 Articles)
Naltrexone
Current Opinion
The Utilization of Low Dose Naltrexone for Chronic Pain
Salomon Poliwoda, Bryant Noss, Gia Thinh D. Truong, Zachary A. Creech, Sarang S. Koushik, Ivan Urits, Omar Viswanath
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Solana Leisher, Adriana Bohorquez, Marcus Gay, Victoria Garcia, Renarda Jones, Dobri Baldaranov, Michael S. Rafii
Affective Disorder
Review Article
GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder
Christopher Sikes-Keilp, David R. Rubinow
Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis
Qian Li, Xin Li, Chong Ye, Miaomiao Jia, Tianmei Si
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
Meredith Castro, Samuel T. Wilkinson, Rayan K. Al Jurdi, Mary Pat Petrillo, Naim Zaki, Stephane Borentain, Dong Jing Fu, Ibrahim Turkoz, Liping Sun, Brianne Brown, Patricia Cabrera
Acute Valproate-Induced Encephalopathy in Status Epilepticus: A Registry-Based Assessment
Valentin Loser, Jan Novy, Isabelle Beuchat, Andrea O. Rossetti